Kala Bio KALA
NASDAQ KALA
$0.16 +0.01 (+6.67%)
At close: Nov 6, 2026 · 4:00 PM EST

Kala Bio (KALA) Short-term Investments (2019 - 2026)

Updated

Kala Bio's Short-term Investments was $7 million in Q2 2026, unchanged from the prior quarter.

Analysis

Kala Bio (KALA) Short-term Investments (2019 - 2026) Analysis & Trends

At the end of FY2022, Short-term Investments at Kala Bio came in at -$38.91 million.

  • In earlier years, Short-term Investments was -$6 million in FY2021, $76.28 million in FY2020 and -$85.45 million in FY2019.
  • Quarterly Short-term Investments has moved between -$38.91 million (Q4 2022) and $9.92 million (Q2 2023) over five years.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,224.11 Bn 1,197.72 Bn 20.46 Bn
2 Johnson & Johnson 665.34 Bn 585.20 Bn 17.30 Bn
3 AbbVie 515.72 Bn 483.73 Bn 13.12 Bn
4 Merck 362.64 Bn 325.58 Bn 13.19 Bn
5 Novartis Ag 315.51 Bn 288.75 Bn -
6 Astrazeneca 289.26 Bn 263.15 Bn 13.26 Bn
7 Amgen 249.20 Bn 200.85 Bn 7.58 Bn
8 Gilead Sciences 207.48 Bn 182.59 Bn 6.73 Bn
9 Pfizer 167.49 Bn 114.85 Bn 12.56 Bn
10 Kala Bio 2.38 Mn -42.27 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 7.00 Mn
Mar 31, 2026 7.00 Mn
Jun 30, 2023 9.92 Mn
Dec 31, 2022 -38.91 Mn
Jun 30, 2022 2.00 Mn
Mar 31, 2022 4.99 Mn
Dec 31, 2021 -6.00 Mn
Sep 30, 2021 -18.38 Mn
Jun 30, 2021 5.00 Mn
Mar 31, 2021 28.02 Mn
Dec 31, 2020 76.28 Mn
Sep 30, 2020 113.59 Mn
Jun 30, 2020 56.54 Mn
Dec 31, 2019 -85.45 Mn
API Access

Kala Bio Short-term Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=short-term-investments&ticker=KALA&period=max&api_key=YOUR_API_KEY